Journal ArticleOPEN ACCESS

ECTRIMS 2021 – Oral Presentations

Multiple Sclerosis Journal (2021) 27(2_suppl) 3-133
DOI: 10.1177/13524585211044647
N/ACitations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Effects of evobrutinib, a Bruton’s tyrosine kinase inhibitor, on slowly expanding lesions: an emerging imaging marker of chronic tissue loss in multiple sclerosis

Cite

CITATION STYLE

APA

ECTRIMS 2021 – Oral Presentations. (2021). Multiple Sclerosis Journal, 27(2_suppl), 3–133. https://doi.org/10.1177/13524585211044647

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free